BioGeneration Ventures
Naarden · Series A–Series B
What they invest in
from 1 of 2 portfolio companiesBiotech ×1Digital Health ×1Medical Devices ×1
HQs:Switzerland×1
Investments · 2 tracked
founders shown can be your intro pathRhyGaze develops gene therapies using optogenetic proteins to restore sight in patients with vision loss caused by retinal photoreceptor dysfunction. The company combines optogenetic technology with gene therapy delivery methods to enable light detection in degenerative eye conditions.
BiotechDigital HealthMedical DevicesBasel, CH
Botond Roska(Researcher (M.D., Ph.D.))Bence György(IOB Assistant Professor & Head of Clinical Translation)Katherine High(CEO)
Frequently asked questions
- What stage does BioGeneration Ventures invest at?
- BioGeneration Ventures invests at the Series A, Series B stages.
- Where is BioGeneration Ventures located?
- BioGeneration Ventures is headquartered in Naarden.
Images
Similar investors
3TS Capital is a technology investment firm with over 25 years of experience managing multiple fund generations. The firm partners with exceptional founders to scale internationally, targeting high-growth SMEs that are either proven local leaders or innovative global challengers.
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.